Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1369543 | Bioorganic & Medicinal Chemistry Letters | 2016 | 5 Pages |
Abstract
Agonists of the angiotensin II receptor type 2 (AT2), a G-protein coupled receptor, promote tissue protective effects in cardiovascular and renal diseases, while antagonists reduce neuropathic pain. We here report detailed molecular models that explain the AT2 receptor selectivity of our recent series of non-peptide ligands. In addition, minor structural changes of these ligands that provoke different functional activity are rationalized at a molecular level, and related to the selectivity for the different receptor conformations. These findings should pave the way to structure based drug discovery of AT2 receptor ligands.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jessica Sallander, Charlotta Wallinder, Anders Hallberg, Johan Åqvist, Hugo Gutiérrez-de-Terán,